AMRN Amarin Corporation plc

+0.07  (2%)
Previous Close 3.29
Open 3.29
Price To book -14.61
Market Cap 909861315
Shares 270,792,058
Volume 1,292,219
Short Ratio 4.41
Av. Daily Volume 1,595,571

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Interim analysis announced September 12, 2016 - trial to proceed. Second interim analysis August 14, 2017 also recommended trial to continue. Final data due 2Q or 3Q 2018.
Vascepa REDUCE-IT outcomes trial
High Triglycerides With Mixed Dyslipidemia

Latest News

  1. ETFs with exposure to Amarin Corp. Plc : October 10, 2017
  2. ETFs with exposure to Amarin Corp. Plc : September 28, 2017
  3. Amarin and HLS Therapeutics Announce Agreement to Commercialize Vascepa® in Canada
  4. Amarin to Present at Cantor Global Healthcare Conference
  5. Amarin Appoints Mark W. Salyer to New Position of Chief Commercial Officer
  6. Amarin to Present at Rodman & Renshaw’s Global Investment Conference
  7. ETFs with exposure to Amarin Corp. Plc : August 31, 2017
  8. Amarin Corp. Plc :AMRN-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
  9. Featured Company News – GlaxoSmithKline Drops Options to Licence Inotersen and IONIS-FB-LRx; Ionis Pharma to Continue Development Independently
  10. Amarin's REDUCE-IT Cardiovascular Outcomes Study of Vascepa to Continue as Planned at Recommendation of Independent Data Monitoring Committee
  11. Edited Transcript of AMRN earnings conference call or presentation 2-Aug-17 12:00pm GMT
  12. Are Options Traders Betting on a Big Move in Amarin (AMRN) Stock?
  13. Amarin reports 2Q loss
  14. Here's Why Amarin Corporation plc Is on the Rise Today
  15. Investor Network: Amarin Corporation Plc to Host Earnings Call
  16. Amarin Reports Second Quarter 2017 Financial Results and Provides Update on Operations
  17. Investor Calendar Invites You to the Amarin Second Quarter 2017 Earnings Conference Call and Webcast Live on Wednesday, August 2, 2017
  18. Amarin to Report Second Quarter 2017 Results and Host Conference Call on August 2, 2017
  19. Here's Why Amarin Corporation plc Surged 34% Higher in June